A Phase I/II Study of Etanercept and Gemcitabine in Patients With Advanced Stage and Chemotherapy Naive Pancreatic Adenocarcinoma.
Phase of Trial: Phase I/II
Latest Information Update: 17 Aug 2015
At a glance
- Drugs Etanercept; Gemcitabine
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Ohio State University Comprehensive Cancer Center
- 31 Aug 2018 Biomarkers information updated
- 27 Jun 2012 Company added in the association field as reported by ClinicalTrials.gov.
- 04 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.